Full text loading...
-
The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
- Source: Current Pharmaceutical Design, Volume 10, Issue 19, Jul 2004, p. 2401 - 2410
-
- 01 Jul 2004
- Previous Article
- Table of Contents
- Next Article
Abstract
As a non-toxic endogenous antioxidant, the semi-essential amino acid taurine is a potential attenuator of oxidative damage such as that produced by ischaemia-reperfusion injury. Ischaemia-reperfusion injury is a well established if paradoxical phenomenon whereby ischaemic tissue, doomed to necrosis if it is not reperfused, is actually further damaged by oxidative attack when perfusion is restored. This paper is a review of the literature concerning therapeutic strategies in ischaemia-reperfusion injury, including nonpharmacological and pharmacological interventions. There is consistent experimental evidence of an important role of taurine in ischaemia-reperfusion injury, with a clinical role emerging in human trials of taurine administered prior to coronary artery bypass grafting and heart valve surgery.